GRS

TRANSLATE

MENU menu

Close close menu

GRS Blog

PAST POSTS menu

Close close menu

So how far would you go to test your product - space?

12/7/2011

Amgen and UCB are going that 'extra mile' and are collaborating with NASA to conduct a preclinical test of a sclerostin antibody that will take place aboard the final space shuttle mission.

 

The space shuttle Atlantis blasted off for the last time on the 8th of July and about 30 mice joined the astronauts on the flight to carry out a bone density study.   More ...

 

Author: Greer Deal, Director of Global Regulatory Services (GRS)

Past Posts...

Stem Cells and Autism
18 September 2011